Brit Mollenhauer

39.3k total citations · 7 hit papers
206 papers, 13.6k citations indexed

About

Brit Mollenhauer is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Brit Mollenhauer has authored 206 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Neurology, 65 papers in Physiology and 50 papers in Molecular Biology. Recurrent topics in Brit Mollenhauer's work include Parkinson's Disease Mechanisms and Treatments (141 papers), Neurological disorders and treatments (77 papers) and Alzheimer's disease research and treatments (55 papers). Brit Mollenhauer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (141 papers), Neurological disorders and treatments (77 papers) and Alzheimer's disease research and treatments (55 papers). Brit Mollenhauer collaborates with scholars based in Germany, United States and Canada. Brit Mollenhauer's co-authors include Claudia Trenkwalder, Friederike Sixel‐Döring, Dag Aarsland, Daniel Weintraub, Michael G. Schlossmacher, Charles H. Adler, Jennifer G. Goldman, Irene Litvan, Alexander I. Tröster and Jaime Kulisevsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Brit Mollenhauer

203 papers receiving 13.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

2012 1.9k citations Daniel Weintraub, Brit Mollenhauer et al. Movement Disorders profile →
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI

2011 585 citations Dag Aarsland, Brit Mollenhauer et al. Movement Disorders profile →
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

2011 489 citations Brit Mollenhauer, Walter Schulz‐Schaeffer et al. profile →
CSF and blood biomarkers for Parkinson's disease

2019 439 citations Oskar Hansson, Omar M. A. El‐Agnaf et al. profile →
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder

2017 405 citations Claudia Trenkwalder, Wolfgang H. Oertel et al. Movement Disorders profile →
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

2016 348 citations Claudia Trenkwalder, Brit Mollenhauer et al. profile →
Characterizing mild cognitive impairment in incident Parkinson disease

2013 330 citations Brit Mollenhauer, Niels Kruse et al. profile →

Peers

Countries citing papers authored by Brit Mollenhauer

Since Specialization

Citations

This map shows the geographic impact of Brit Mollenhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brit Mollenhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brit Mollenhauer more than expected).

Fields of papers citing papers by Brit Mollenhauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brit Mollenhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brit Mollenhauer. The network helps show where Brit Mollenhauer may publish in the future.

Co-authorship network of co-authors of Brit Mollenhauer

This figure shows the co-authorship network connecting the top 25 collaborators of Brit Mollenhauer. A scholar is included among the top collaborators of Brit Mollenhauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brit Mollenhauer. Brit Mollenhauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Toward a biological definition of neuronal and glial synucleinopathies 2025 ·Nature Medicine ·Claudio Soto, Brit Mollenhauer, Oskar Hansson, Un Jung Kang, Roy N. Alcalay, David G. Standaert, Claudia Trenkwalder, Kenneth Marek, Douglas Galasko, Kathleen L. Poston	5
2	Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s Disease 2025 ·International Journal of Molecular Sciences ·Mary Xylaki, (unknown), (unknown), Joseph Schérer, (unknown), Mohammed Dakna, Michael Bartl, Sandrina Weber, Sebastian Schade, Christof Lenz, Brit Mollenhauer	0
3	A network perspective on cognition in individuals with Parkinson's disease 2025 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·(unknown), Elke Kalbe, Monika Balzer‐Geldsetzer, Daniela Berg, (unknown), Jan Kassubek, Inga Liepelt‐Scarfone, Brit Mollenhauer, Kathrin Reetz, Oliver Riedel, Sandra Roeske, Jörg B. Schulz, Alexander Storch, Claudia Trenkwalder, Karsten Witt, Hans‐Ulrich Wïttchen, Richard Dodel, Anja Ophey	0
4	Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform 2025 ·EMBO Molecular Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sandrina Weber, Eun‐Hae Kwon, Robin Wanka, Carsten Kötting, Jörn Güldenhaupt, Léon Beyer, Lars Tönges, Brit Mollenhauer, Klaus Gerwert	1
5	Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice 2024 ·Movement Disorders ·Tiago F. Outeiro, Lorraine V. Kalia, Erwan Bézard, Juan E. Ferrario, Chin‐Hsien Lin, Mohamed Salama, David G. Standaert, (unknown), Ryōsuke Takahashi, Miquel Vila, Brit Mollenhauer, Per Svenningsson	1
6	Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach 2024 ·Movement Disorders ·Connie Marras, Seyed‐Mohammad Fereshtehnejad, Daniela Berg, Nicolaas I. Bohnen, Kathy Dujardin, Roberto Erro, Alberto J. Espay, Glenda M. Halliday, Jacobus J. van Hilten, (unknown), Beomseok Jeon, Christine Klein, Albert F.G. Leentjens, Brit Mollenhauer, Ronald B. Postuma, Mayela Rodríguez‐Violante, Tanya Simuni, Daniel Weintraub, Michael Lawton, Tiago Mestre	21
7	C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study 2023 ·Alzheimer s & Dementia ·Madhurima Chatterjee, (unknown), (unknown), Marleen J.A. Koel‐Simmelink, Walter Boiten, Lars Piepkorn, Thang V. Pham, Davide Chiasserini, Sander R. Piersma, Jaco C. Knol, (unknown), Brit Mollenhauer, Wiesje M. van der Flier, Connie R. Jiménez, Charlotte E. Teunissen, Olaf Jahn, Anja Schneider	25
8	Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta‐Analysis 2023 ·Movement Disorders ·Mary Xylaki, (unknown), Sandrina Weber, Michael Bartl, Tiago F. Outeiro, Brit Mollenhauer	36
9	LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts 2023 ·npj Parkinson s Disease ·Kalpana Merchant, Tanya Simuni, (unknown), Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman, (unknown), F. Hsieh, Roy N. Alcalay, Christopher S. Coffey, Lana M. Chahine, Tatiana Foroud, Andrew Singleton, Daniel Weintraub, Samantha J. Hutten, Todd Sherer, Brit Mollenhauer, Andrew Siderowf, Caroline M. Tanner, Kenneth Marek, (unknown)	12
10	Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease” 2023 ·Movement Disorders ·Tiago F. Outeiro, Roy N. Alcalay, Angelo Antonini, Johannes Attems, Vincenzo Bonifati, Francisco Cardoso, Marie‐Françoise Chesselet, John Hardy, Graziella Madeo, Ian G. McKeith, Brit Mollenhauer, Darren J. Moore, Olivier Rascol, Michael G. Schlossmacher, Hermona Soreq, Leonidas Stefanis, Joaquim J. Ferreira	20
11	Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression 2023 ·Journal of Parkinson s Disease ·Michael C. Brumm, Andrew Siderowf, Tanya Simuni, (unknown), Seung Ho Choi, Chelsea Caspell‐Garcia, Lana M. Chahine, Brit Mollenhauer, Tatiana Foroud, Douglas Galasko, Kalpana Merchant, Vanessa Arnedo, Samantha J. Hutten, (unknown), Kathleen L. Poston, Caroline M. Tanner, Daniel Weintraub, Karl Kieburtz, Kenneth Marek, Christopher S. Coffey, (unknown)	25
12	Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease 2022 ·npj Parkinson s Disease ·Pilar Gómez‐Garre, (unknown), Silvia Jesús, (unknown), Paolo Garagnani, Brit Mollenhauer, Chiara Pirazzini, Federica Provini, Claudia Trenkwalder, Claudio Franceschi, Pablo Mir	2
13	Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline 2022 ·Diagnostics ·(unknown), Péter Hermann, Daniela Varges, (unknown), Stefan Goebel, (unknown), Fabian Maass, Matthias Schmitz, Franc Llorens, Niels Kruse, Paul Lingor, Brit Mollenhauer, Inga Zerr	1
14	A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study 2021 ·Parkinsonism & Related Disorders ·(unknown), Anja Ophey, Jörg B. Schulz, Kathrin Reetz, (unknown), Alexander Storch, Inga Liepelt‐Scarfone, Sara Becker, Daniela Berg, Monika Balzer‐Geldsetzer, Jan Kassubek, (unknown), Karsten Witt, Brit Mollenhauer, Claudia Trenkwalder, Sandra Roeske, Hans‐Ulrich Wïttchen, Oliver Riedel, Richard Dodel, Elke Kalbe	10
15	Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase 2021 ·npj Parkinson s Disease ·Anouke van Rumund, Lukas Pavelka, Rianne A.J. Esselink, (unknown), Ron A. Wevers, Brit Mollenhauer, Rejko Krüger, Bastiaan R. Bloem, Marcel M. Verbeek	16
16	Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics 2021 ·ISME Communications ·(unknown), Antoine Malabirade, Javier Ramiro‐Garcia, Janine Habier, Jean‐Pierre Trezzi, Samantha L. Peters, (unknown), Rashi Halder, Christian Jäger, Susheel Bhanu Busi, Patrick May, Wolfgang H. Oertel, Brit Mollenhauer, Cédric C. Laczny, Robert L. Hettich, Paul Wilmes	5
17	Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease 2021 ·npj Parkinson s Disease ·Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal A. Lashuel, David Sulzer, Kostas Vekrellis, Glenda M. Halliday, Julianna J. Tomlinson, Michael G. Schlossmacher, Poul Henning Jensen, Julia M. Schulze‐Hentrich, Olaf Rieß, Warren D. Hirst, Omar M. A. El‐Agnaf, Brit Mollenhauer, Peter T. Lansbury, Tiago F. Outeiro	96
18	Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia 2016 ·Movement Disorders ·Carla Abdelnour, Inger van Steenoven, Elisabet Londos, ‪Frederic Blanc‬, Bjørn Auestad, Milica G. Kramberger, Henrik Zetterberg, Brit Mollenhauer, Merçé Boada, Dag Aarsland	70
19	Movement disturbances in the differential diagnosis of Creutzfeldt‐Jakob disease 2008 ·Movement Disorders ·(unknown), Brit Mollenhauer, Uta Heinemann, Daniela Varges, Carola Werner, Inga Zerr, Walter Schulz‐Schaeffer	16
20	Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations 2007 ·Journal of Neural Transmission ·Mirko Bibl, Brit Mollenhauer, Sebastián Wolf, Hermann Esselmann, Piotr Lewczuk, Johannes Kornhuber, Jens Wiltfang	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact